Alexine Tranquada is a seasoned pharmaceutical and biotech executive, she brings deep expertise across customer insights, market access, commercial strategy, and business development, with a career-long focus on improving patient outcomes and advancing more equitable, sustainable healthcare systems.

Alexine is Chief Growth Officer at Radicus Tech, where she leads global strategy, commercial expansion for a fast-growing healthcare technology platform. A previously held senior roles at Schering-Plough and Merck, where she helped shape commercial and portfolio strategy across multiple therapeutic areas. Her work included evaluating key pipeline assets, optimizing go-to-market approaches, and supporting public health initiatives that contributed to both high-visibility strategic programs and major corporate acquisitions.

Alexine is an active advisor to early-stage biotech and health-tech companies, providing guidance on market positioning, evidence strategy, and partnership development. She also collaborates closely with accelerators and innovation ecosystems, including Health Wildcatters, MassChallenge, Healthcare Shares, Springboard, Ignite, and UT Southwestern’s Dolphin Tank, helping founders refine value propositions and accelerate commercialization.

Alexine serves on several mission-driven boards, including the Healthcare Businesswomen’s Association as President of Corporate Relations and the Gwen Lily Research Foundation, and is deeply committed to mentorship. She supports emerging leaders through the Young Women’s Preparatory Network and HBA, championing workforce development and pathways for women in healthcare.

Beyond her professional work, Alexine is an avid traveler and athlete, competing in triathlons. She enjoys spending time with her husband, Warren, and their three children—Ella, Calvin, and Miles.